Physicians now have
robust data to
help them counsel patients and make informed decisions regarding treatment options,» says study co-author Lloyd P. Aiello, M.D., Ph.D., Professor of Ophthalmology at Harvard Medical School, Director of Joslin's Beetham Eye Institute, co-head of Joslin's
Section of Vascular Cell Biology, and founding chair of the DRCR Network.